Response to Anti-hypertensives in Pregnant and Postpartum Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.

Also called NCT03506724

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 109 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03506724
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03506724. Randomized; no masking; primary purpose treatment. Start 2017-09-11 (actual); primary completion 2019-04-05 (actual). Results posted on 2021-05-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Response to Anti-hypertensives in Pregnant and Postpartum Patients
Condition
Hypertension in Pregnancy
Condition
Preeclampsia
Intervention (Drug)
Nifedipine
Intervention (Drug)
Labetalol
Lead sponsor
Icahn School of Medicine at Mount Sinai (class: other)
Collaborator
Mount Sinai Hospital, New York (class: other)
Collaborator
Maimonides Medical Center (class: other)

Record details

Record id
cardio:ct-nct03506724
Content hash
8df8ad0150d12aa3c443490399ff3038822c67e0afc7625f70ac7a02e2db3126